Fi­nal­ly, Cel­gene wins. Ane­mia drug lus­pa­ter­cept — part­nered with Ac­celeron — scores in PhI­II tri­al

Af­ter Cel­gene’s many trips and blun­ders this year, the phar­ma gi­ant might fi­nal­ly please in­vestors Thurs­day with cheery news from one of its late-stage block­buster …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER